INTERPACE BIOSCIENCES, INC. Quarterly Amortization of Intangible Assets in USD from Q2 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Interpace Biosciences, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2011 to Q4 2023.
  • Interpace Biosciences, Inc. Amortization of Intangible Assets for the quarter ending December 31, 2023 was $100K, a 75% decline year-over-year.
  • Interpace Biosciences, Inc. Amortization of Intangible Assets for the twelve months ending December 31, 2023 was $900K, a 30.8% decline year-over-year.
  • Interpace Biosciences, Inc. annual Amortization of Intangible Assets for 2023 was $900K, a 30.8% decline from 2022.
  • Interpace Biosciences, Inc. annual Amortization of Intangible Assets for 2022 was $1.3M, a 59.4% decline from 2021.
  • Interpace Biosciences, Inc. annual Amortization of Intangible Assets for 2021 was $3.2M, a 28.9% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $900K $100K -$300K -75% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $1.2M $200K -$100K -33.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $1.3M $300K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.3M $300K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $1.3M $400K +$300K +300% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $1M $300K -$600K -66.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $1.6M $300K -$800K -72.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $2.4M $300K -$800K -72.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $3.2M $100K -$1.1M -91.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 $4.3M $900K -$200K -18.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $4.5M $1.1M $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $4.5M $1.1M $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $4.5M $1.2M $0 0% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $4.5M $1.1M $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $4.5M $1.1M +$300K +37.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $4.2M $1.1M +$200K +22.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $4M $1.2M $0 0% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-01
Q3 2019 $4M $1.1M +$300K +37.5% Jul 1, 2019 Sep 30, 2019 10-Q 2021-01-20
Q2 2019 $3.7M $800K $0 0% Apr 1, 2019 Jun 30, 2019 10-Q/A 2021-01-19
Q1 2019 $3.7M $900K +$100K +12.5% Jan 1, 2019 Mar 31, 2019 10-Q/A 2021-01-19
Q4 2018 $3.6M $1.2M +$13.5M Oct 1, 2018 Dec 31, 2018 10-K/A 2021-01-19
Q3 2018 -$9.88M $800K -$4.46M -84.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$5.42M $800K -$4.38M -84.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$1.04M $800K -$4.29M -84.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $3.25M -$12.3M -$4.08M -49.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-21
Q3 2017 $7.33M $5.26M +$762K +16.9% Jul 1, 2017 Sep 30, 2017 10-K/A 2021-01-19
Q2 2017 $6.57M $5.18M +$1.19M +29.8% Apr 1, 2017 Jun 30, 2017 10-K/A 2021-01-19
Q1 2017 $5.38M $5.09M +$1.61M +46.4% Jan 1, 2017 Mar 31, 2017 10-K/A 2021-01-19
Q4 2016 $3.77M -$8.2M -$6.16M -302% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-23
Q3 2016 $9.93M $4.5M +$2.04M +82.9% Jul 1, 2016 Sep 30, 2016 10-K/A 2021-01-19
Q2 2016 $7.89M $3.99M +$2.04M +105% Apr 1, 2016 Jun 30, 2016 10-K/A 2021-01-19
Q1 2016 $5.85M $3.48M +$2.04M +141% Jan 1, 2016 Mar 31, 2016 10-K/A 2021-01-19
Q4 2015 $3.81M -$2.04M -$2.7M -412% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 $6.51M $2.46M +$2.34M +1986% Jul 1, 2015 Sep 30, 2015 10-K/A 2021-01-19
Q2 2015 $4.17M $1.95M +$1.95M Apr 1, 2015 Jun 30, 2015 10-K/A 2021-01-19
Q1 2015 $2.21M $1.44M +$1.44M Jan 1, 2015 Mar 31, 2015 10-K/A 2021-01-19
Q4 2014 $773K $655K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $118K Jul 1, 2014 Sep 30, 2014 10-K/A 2021-01-19
Q2 2014 $0 Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $0 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2012 $900K $300K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-06
Q3 2012 $200K $0 0% Jul 1, 2012 Sep 30, 2012 10-Q/A 2014-09-30
Q2 2012 $200K $0 0% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-05
Q1 2012 $200K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q3 2011 $200K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $200K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.